Roche Launches Genomic Profiling Kit
On Monday, Roche announced the development of a new genomic profiling kit that will allow cancer researchers to investigate tumours without needing to send tissue samples to centralised laboratories.
The AVENIO Tumour Tissue Comprehensive Genomic Profiling (CGP) Kit was developed with Roche unit Foundation Medicine, a molecular information specialist whose products help doctors match patients to appropriate therapies and clinical trials.
"The Kit complements the current CGP portfolio offered by Roche and Foundation Medicine and allows laboratories to expand their oncology research in-house," Roche said in a statement, giving no financial information about the product.
Ultimately, a future version of the kit may lead to additional resources for clinicians to use in the diagnosis and treatment of cancer.
(Reuters)
